A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism

Contraception - Tập 84 - Trang 508-511 - 2011
Gokalp Oner1, Iptisam Ipek Muderris1
1Department of Obstetrics and Gynecology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey

Tài liệu tham khảo

Barbieri, 1990, Hyperandrogenic disorders, Clin Obstet Gynecol, 33, 640, 10.1097/00003081-199009000-00028 Knochenhauer, 1995, Advances in the diagnosis and treatment of the hirsute patient, Curr Opin Obstet Gynecol, 7, 344, 10.1097/00001703-199510000-00004 Gregoriou, 2008, Treatment of hirsutism with combined pill containing drospirenone, Gynecol Endocrinol, 24, 220, 10.1080/09513590801948309 Oláh, 2004, The modern management of hirsutism, Rev Gynaecol Practise, 4, 211, 10.1016/j.rigp.2004.05.001 Murphy, 1990, Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women, Fertil Steril, 53, 35, 10.1016/S0015-0282(16)53212-9 Azziz, 2003, The evaluation and management of hirsutism, Obstet Gynecol, 101, 995, 10.1016/S0029-7844(02)02725-4 Krattenmacher, 2000, Drospirenone: pharmacology and pharmacokinetics of unique progestogen, Contraception, 62, 29, 10.1016/S0010-7824(00)00133-5 van Vloten, 2002, The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea, Cutis, 69, 2 Thorneycroft, 2004, Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment, Cutis, 74, 123 Batukan, 2006, Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism, Fertil Steril, 85, 436, 10.1016/j.fertnstert.2005.07.1311 Kriplani, 2010, Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome, Contraception, 82, 139, 10.1016/j.contraception.2010.02.009 Bachmann, 2004, Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone, Contraception, 70, 191, 10.1016/j.contraception.2004.05.013 Pearlstein, 2005, Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation, Contraception, 72, 414, 10.1016/j.contraception.2005.08.021 Koltun, 2008, Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial, Contraception, 77, 249, 10.1016/j.contraception.2007.11.003 Homburg, 2002, What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome, Hum Reprod, 17, 2495, 10.1093/humrep/17.10.2495 Hatch, 1981, Hirsutism: implications, etiology, and management, Am J Obstet Gynecol, 140, 815, 10.1016/0002-9378(81)90746-8 Blode, 2000, A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers, Eur J Contracept Reprod Health Care, 5, 256, 10.1080/13625180008500407 Guido, 2004, Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study, J Clin Endocrinol Metab, 89, 2817, 10.1210/jc.2003-031158 Sulak, 2002, Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms, Am J Obstet Gynecol, 186, 1142, 10.1067/mob.2002.122988 Keam, 2003, Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive, Treat Endocrinol, 2, 49, 10.2165/00024677-200302010-00005 Batukan, 2007, Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism, Gynecol Endocrinol, 23, 38, 10.1080/09637480601137066 Bruni Bresciani, 2010, Extracontraceptive benefits of EE/DRSP (Yaz) in 24+4 day regimen, Minerva Ginecol, 62, 261 Cremer, 2010, Recent innovations in oral contraception, Semin Reprod Med, 28, 140, 10.1055/s-0030-1248139